Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,988 | 15,311 | 20,772 | 28,980 | 32,325 |
| Marketable Securities | N/A | N/A | 10,291 | 6,375 | 21,541 |
| Receivables | 1,882 | 3,155 | 3,330 | 1,830 | 2,932 |
| Inventories | 210 | 1,819 | 76 | 566 | 92 |
| Other current assets | 551 | 1,304 | 0 | 0 | 0 |
| TOTAL | $15,631 | $21,589 | $34,469 | $37,751 | $56,890 |
| Non-Current Assets | |||||
| PPE Net | 812 | 1,804 | 2,455 | 2,499 | 2,073 |
| Investments And Advances | 614 | 94 | 28 | 74 | 25 |
| Intangibles | 0 | 12,195 | 13,169 | 14,140 | 15,207 |
| Other Non-Current Assets | 2,989 | 4,182 | 980 | 1,662 | 2,109 |
| TOTAL | $4,415 | $18,275 | $16,632 | $18,375 | $19,414 |
| Total Assets | $20,046 | $39,864 | $51,101 | $56,126 | $76,304 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,088 | 2,307 | 2,804 | 2,653 | 2,982 |
| Accrued Expenses | 861 | 1,869 | 2,537 | 1,987 | 2,662 |
| Other current liabilities | 762 | 13,570 | 388 | 79 | 89 |
| TOTAL | $3,444 | $18,695 | $6,944 | $5,625 | $6,882 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17 | 360 | 362 | 22 | 175 |
| Other Non-Current Liabilities | 3,897 | 7,810 | 17,154 | 18,917 | 8,654 |
| TOTAL | $4,627 | $6,331 | $15,472 | $15,711 | $6,002 |
| Total Liabilities | $8,071 | $25,026 | $22,416 | $21,336 | $12,884 |
| Shareholders' Equity | |||||
| Common Shares | 488 | 363 | 286 | 235 | 234 |
| Retained earnings | -282,556 | -274,071 | -257,586 | -233,707 | -207,069 |
| Other shareholders' equity | 12,057 | 16,289 | 16,632 | 6,860 | 9,767 |
| TOTAL | $11,975 | $14,838 | $28,685 | $34,790 | $63,420 |
| Total Liabilities And Equity | $20,046 | $39,864 | $51,101 | $56,126 | $76,304 |